RESIDENCY Flashcards Preview

Pedia > RESIDENCY > Flashcards

Flashcards in RESIDENCY Deck (38):
1

When to do ABG after hooking to mech vent

Within an hour

2

Mech vent: How to set TV

6-8cc/kg

3

Mech vent: How to set FiO2

Begin wih 100, wean as tolerated

4

Mech vent: How to set PEEP

Begin with 5

5

ABG parameter to measure oxygenation

PO2

6

ABG parameter to measure ventilation

PCO2

7

Parameters to manipulate to alter oxygenation (PO2)

1) FiO2
2) PEEP
3) I-time

8

Parameters to manipulate to alter ventilation (PCO2)

1) RR
2) TV
3) Shorten I-time to lengthen E-time

9

Proper ET size

(Age/4) + 4 OR

10

ET length

Size x 3 OR
Wt. + 6 OR
(Age/2) + 12

11

Mech vent: How to set rate

Infant: 25-30/min
Child: 15-20/min
Teen: 10-14/min

12

Incidence of hemophilia A

1/10,000 male births

13

Incidence of hemophilia B

1/30,000 male births

14

Symptomatic female carriers of hemophilia A

30%

15

Factors that increase risk of inhibitor development

Surgery
Infection
Most important: Genetics (gene mutation)

16

% factor activity goal in hemophilia in Phils in factor transfusion

60-80%
(100% in developed countries)

17

% factor activity for adequate hemostasis (hemophilia)

30%

18

How to screen for inhibitors in patients with hemophilia

Mixing studies (px plasma + normal plasma --> aPtt: 60% increase from baseline = no inhibitor)

19

Indications for admission of hemophiliac patients

1) Life-threatening bleed (excluding hemarthroses)
2) Non-life-threatening bleed IF known to have inhibitor

20

Phenobarbital, side effect (WOF when loading)

Respiratory depression

21

Incidence of hemophilia A

1/10,000 male birthd

22

Incidence of hemophilia B

1/30,000 male births

23

Symptomatic female carriers of hemophilia A

30%

24

Factors that increase risk of inhibitor development

Surgery
Infection
Most important: Genetics (gene mutation)

25

% factor activity goal in hemophilia in Phils in factor transfusion

60-80%
(100% in developed countries)

26

% factor activity for adequate hemostasis (hemophilia)

30%

27

How to screen for inhibitors in patients with hemophilia

Mixing studies (px plasma + normal plasma --> aPtt: 60% increase from baseline = no inhibitor)

28

Indications for admission of hemophiliac patients

1) Life-threatening bleed (excluding hemarthroses)
2) Non-life-threatening bleed IF known to have inhibitor

29

Phenobarbital, side effect (WOF when loading)

Respiratory depression

30

Incidence of hemophilia A

1/10,000 male birthd

31

Incidence of hemophilia B

1/30,000 male births

32

Symptomatic female carriers of hemophilia A

30%

33

Factors that increase risk of inhibitor development

Surgery
Infection
Most important: Genetics (gene mutation)

34

% factor activity goal in hemophilia in Phils in factor transfusion

60-80%
(100% in developed countries)

35

% factor activity for adequate hemostasis (hemophilia)

30%

36

How to screen for inhibitors in patients with hemophilia

Mixing studies (px plasma + normal plasma --> aPtt: 60% increase from baseline = no inhibitor)

37

Indications for admission of hemophiliac patients

1) Life-threatening bleed (excluding hemarthroses)
2) Non-life-threatening bleed IF known to have inhibitor

38

Phenobarbital, side effect (WOF when loading)

Respiratory depression